Given this close relationship, scientists have hoped that semaglutide and similar drugs that mimic the hormone GLP-1 (already approved to treat obesity and diabetes) could be an effective treatment for MASLD/MASH as well
For weight loss maintenance, 200-300 minutes weekly may be more effective
Practical considerations for safety and consistency: Use a new sterile insulin syringe for every injection Rotate injection locations to reduce local irritation Inject slowly and wait briefly before removing needle Track daily dosing and site rotation for consistency Human clinical evidence remains limited
Image Credit: Juan Gaertner / Shutterstock.com Introduction Emerging evidence suggests that specific foods, nutrients, and lifestyle habits can stimulate the release of glucagon-like peptide 1 (GLP-1), improve appetite control, and support cardiometabolic balance
However, Ozempic quickly gained attention for its weight loss benefits, leading to widespread off-label use by weight loss patients